194 related articles for article (PubMed ID: 29032173)
1. The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.
Tahaei SE; Couasnay G; Ma Y; Paria N; Gu J; Lemoine BF; Wang X; Rios JJ; Elefteriou F
Bone; 2018 Jan; 106():103-111. PubMed ID: 29032173
[TBL] [Abstract][Full Text] [Related]
2. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
[TBL] [Abstract][Full Text] [Related]
3. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
4. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.
Paria N; Khalid A; Shen B; Lemoine B; Chan J; Kidane YH; Oxendine I; Cornelia R; Wise CA; Rios JJ
J Bone Miner Res; 2023 Feb; 38(2):288-299. PubMed ID: 36459048
[TBL] [Abstract][Full Text] [Related]
7. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
8. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 signaling is essential for neurofibromatosis type I gene modulated osteogenic differentiation of BMSCs.
Li Y; Li J; Zhou Q; Liu Y; Chen W; Xu H
J Cell Biochem; 2019 Mar; 120(3):2886-2896. PubMed ID: 29266342
[TBL] [Abstract][Full Text] [Related]
10. JNK inhibitors increase osteogenesis in Nf1-deficient cells.
Sullivan K; El-Hoss J; Little DG; Schindeler A
Bone; 2011 Dec; 49(6):1311-6. PubMed ID: 21964323
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.
Wu X; Estwick SA; Chen S; Yu M; Ming W; Nebesio TD; Li Y; Yuan J; Kapur R; Ingram D; Yoder MC; Yang FC
Hum Mol Genet; 2006 Oct; 15(19):2837-45. PubMed ID: 16893911
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
Baht GS; Nadesan P; Silkstone D; Alman BA
Bone; 2017 May; 98():31-36. PubMed ID: 28254468
[TBL] [Abstract][Full Text] [Related]
13. The neurofibromatosis type I gene promotes autophagy via mTORC1 signalling pathway to enhance new bone formation after fracture.
Tan Q; Wu JY; Liu YX; Liu K; Tang J; Ye WH; Zhu GH; Mei HB; Yang G
J Cell Mol Med; 2020 Oct; 24(19):11524-11534. PubMed ID: 32862562
[TBL] [Abstract][Full Text] [Related]
14. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/β-catenin signaling pathway.
Hang K; Ye C; Xu J; Chen E; Wang C; Zhang W; Ni L; Kuang Z; Ying L; Xue D; Pan Z
Stem Cell Res Ther; 2019 Jun; 10(1):189. PubMed ID: 31238979
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
Wang W; Nyman JS; Ono K; Stevenson DA; Yang X; Elefteriou F
Hum Mol Genet; 2011 Oct; 20(20):3910-24. PubMed ID: 21757497
[TBL] [Abstract][Full Text] [Related]
16. Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.
Chen M; Lu L; Cheng D; Zhang J; Liu X; Zhang J; Zhang T
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446790
[TBL] [Abstract][Full Text] [Related]
17. A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.
El-Hoss J; Cheng T; Carpenter EC; Sullivan K; Deo N; Mikulec K; Little DG; Schindeler A
J Bone Joint Surg Am; 2014 Jul; 96(14):e117. PubMed ID: 25031379
[TBL] [Abstract][Full Text] [Related]
18. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells.
Zhang W; Dong R; Diao S; Du J; Fan Z; Wang F
Stem Cell Res Ther; 2017 Feb; 8(1):30. PubMed ID: 28173844
[TBL] [Abstract][Full Text] [Related]
19. Cellular hypoxia promotes osteogenic differentiation of mesenchymal stem cells and bone defect healing via STAT3 signaling.
Yu X; Wan Q; Ye X; Cheng Y; Pathak JL; Li Z
Cell Mol Biol Lett; 2019; 24():64. PubMed ID: 31827540
[TBL] [Abstract][Full Text] [Related]
20. A dual role of cholesterol in osteogenic differentiation of bone marrow stromal cells.
Li K; Xiu C; Zhou Q; Ni L; Du J; Gong T; Li M; Saijilafu ; Yang H; Chen J
J Cell Physiol; 2019 Mar; 234(3):2058-2066. PubMed ID: 30317648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
